In this video we discuss the use of biomarker-guided treatment in phase I trials, which can yield high response rates.
Maria Schwaederle, PharmD
Advertisement
Articles by Maria Schwaederle, PharmD
Advertisement
Latest Updated Articles
Precision Medicine in Phase I Cancer TrialsPublished: June 22nd 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
